International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 3, pp. 686 - 692
Purpose To report long-term survival and toxicity outcomes with the use of high-dose intensity modulated radiation therapy (IMRT) to 86.4 Gy for patients with...
Radiology | Hematology, Oncology and Palliative Medicine | MORTALITY | 80 GY | IMRT | ONCOLOGY | CONFORMAL RADIOTHERAPY | RANDOMIZED-TRIAL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Urogenital System - radiation effects | Gastrointestinal Tract - radiation effects | Male | Penile Erection | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Disease-Free Survival | Prostate - pathology | Neoplasm Grading | Analysis of Variance | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Care and treatment | Radiotherapy | Nuclear radiation | Prostate cancer | Patient outcomes | Cancer | Index Medicus | PROSTATE | PATIENTS | NEOPLASMS | BIOPSY | METASTASES | RADIATION DOSES | TOXICITY | MULTIVARIATE ANALYSIS | HEALTH HAZARDS | RISK ASSESSMENT | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | ANDROGENS
Radiology | Hematology, Oncology and Palliative Medicine | MORTALITY | 80 GY | IMRT | ONCOLOGY | CONFORMAL RADIOTHERAPY | RANDOMIZED-TRIAL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Urogenital System - radiation effects | Gastrointestinal Tract - radiation effects | Male | Penile Erection | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Disease-Free Survival | Prostate - pathology | Neoplasm Grading | Analysis of Variance | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Care and treatment | Radiotherapy | Nuclear radiation | Prostate cancer | Patient outcomes | Cancer | Index Medicus | PROSTATE | PATIENTS | NEOPLASMS | BIOPSY | METASTASES | RADIATION DOSES | TOXICITY | MULTIVARIATE ANALYSIS | HEALTH HAZARDS | RISK ASSESSMENT | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | ANDROGENS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 2, pp. 312 - 319
Purpose To identify an anatomic structure predictive for acute (AUT) and late (LUT) urinary toxicity in patients with prostate cancer treated with...
Radiology | Hematology, Oncology and Palliative Medicine | CANCER PATIENTS | SEED IMPLANTATION | MORBIDITY | ONCOLOGY | ACUTE URINARY RETENTION | BEAM RADIATION-THERAPY | RISK | INTERMEDIATE | INTERSTITIAL BRACHYTHERAPY | URETHRAL DOSIMETRY | I-125 PROSTATE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Prostatic Neoplasms - radiotherapy | Area Under Curve | Humans | Middle Aged | Brachytherapy - methods | Male | Urinary Bladder - radiation effects | Iodine Radioisotopes - therapeutic use | Analysis of Variance | Palladium - therapeutic use | Urination Disorders - etiology | ROC Curve | Aged | Retrospective Studies | Brachytherapy - adverse effects | Radioisotope brachytherapy | Prostate cancer | PROSTATE | PATIENTS | BALLOONS | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION DOSES | TOXICITY | IODINE 125 | CAT SCANNING | PALLADIUM 103 | PLANNING | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | NECK | BRACHYTHERAPY | DOSE RATES
Radiology | Hematology, Oncology and Palliative Medicine | CANCER PATIENTS | SEED IMPLANTATION | MORBIDITY | ONCOLOGY | ACUTE URINARY RETENTION | BEAM RADIATION-THERAPY | RISK | INTERMEDIATE | INTERSTITIAL BRACHYTHERAPY | URETHRAL DOSIMETRY | I-125 PROSTATE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Prostatic Neoplasms - radiotherapy | Area Under Curve | Humans | Middle Aged | Brachytherapy - methods | Male | Urinary Bladder - radiation effects | Iodine Radioisotopes - therapeutic use | Analysis of Variance | Palladium - therapeutic use | Urination Disorders - etiology | ROC Curve | Aged | Retrospective Studies | Brachytherapy - adverse effects | Radioisotope brachytherapy | Prostate cancer | PROSTATE | PATIENTS | BALLOONS | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION DOSES | TOXICITY | IODINE 125 | CAT SCANNING | PALLADIUM 103 | PLANNING | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | NECK | BRACHYTHERAPY | DOSE RATES
Journal Article
Brachytherapy, ISSN 1538-4721, 2017
Abstract Brachytherapy is an ideal treatment approach for radiorecurrent prostate cancer given the highly conformal treatment. Increasingly, multiparametric...
Radiology | Hematology, Oncology and Palliative Medicine
Radiology | Hematology, Oncology and Palliative Medicine
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 3, pp. 588 - 594
Purpose To compare the potential benefits of continuous monitoring of prostate position and intervention (CMI) using 2-mm displacement thresholds during...
Radiology | Hematology, Oncology and Palliative Medicine | IMAGE-GUIDED RADIOTHERAPY | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | STEREOTACTIC BODY RADIOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | Prostatic Neoplasms - surgery | Time Factors | Radiotherapy Planning, Computer-Assisted - methods | Humans | Dose Fractionation | Male | Patient Positioning - instrumentation | Imaging, Three-Dimensional | Radiosurgery - methods | Feasibility Studies | Radiotherapy Setup Errors - prevention & control | Radiotherapy, Intensity-Modulated | PROSTATE | PATIENTS | APPROXIMATIONS | BIOMEDICAL RADIOGRAPHY | MONITORING | RADIATION DOSES | COMPARATIVE EVALUATIONS | RADIOWAVE RADIATION | PLANNING | IMAGES | ADMINISTRATIVE PROCEDURES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | TIME DEPENDENCE
Radiology | Hematology, Oncology and Palliative Medicine | IMAGE-GUIDED RADIOTHERAPY | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | STEREOTACTIC BODY RADIOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | Prostatic Neoplasms - surgery | Time Factors | Radiotherapy Planning, Computer-Assisted - methods | Humans | Dose Fractionation | Male | Patient Positioning - instrumentation | Imaging, Three-Dimensional | Radiosurgery - methods | Feasibility Studies | Radiotherapy Setup Errors - prevention & control | Radiotherapy, Intensity-Modulated | PROSTATE | PATIENTS | APPROXIMATIONS | BIOMEDICAL RADIOGRAPHY | MONITORING | RADIATION DOSES | COMPARATIVE EVALUATIONS | RADIOWAVE RADIATION | PLANNING | IMAGES | ADMINISTRATIVE PROCEDURES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | TIME DEPENDENCE
Journal Article
Brachytherapy, ISSN 1538-4721, 2017, Volume 16, Issue 3, pp. S49 - S50
Journal Article
Brachytherapy, ISSN 1538-4721, 2017, Volume 16, Issue 3, pp. S110 - S110
Journal Article
Brachytherapy, ISSN 1538-4721, 2014, Volume 13, pp. S124 - S124
Journal Article
Brachytherapy, ISSN 1538-4721, 2016, Volume 15, pp. S48 - S49
Journal Article
Brachytherapy, ISSN 1538-4721, 2014, Volume 13, pp. S120 - S120
Journal Article
Brachytherapy, ISSN 1538-4721, 2013, Volume 12, pp. S11 - S11
Journal Article
Brachytherapy, ISSN 1538-4721, 2013, Volume 12, pp. S32 - S33
Journal Article
Advances in Radiation Oncology, ISSN 2452-1094, 2019, Volume 4, Issue 3, pp. 492 - 499
AbstractPurposeTo report 15-year outcomes for dose-escalated intensity modulated radiation therapy (IMRT) for localized prostate cancer (PC) by evaluating...
Hematology, Oncology, and Palliative Medicine
Hematology, Oncology, and Palliative Medicine
Journal Article
Brachytherapy, ISSN 1538-4721, 2017, Volume 16, Issue 3, pp. S64 - S64
Journal Article
Advances in Radiation Oncology, ISSN 2452-1094, 2018, Volume 4, Issue 2, pp. 337 - 344
Abstract Purpose This study aimed to evaluate the toxicity of prostate and pelvic lymph node stereotactic body radiation therapy (SBRT) for high-risk prostate...
Hematology, Oncology, and Palliative Medicine
Hematology, Oncology, and Palliative Medicine
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 2, pp. 339 - 344
Purpose To determine the potential association between genitourinary (GU) toxicity and planning dose–volume parameters for GU pelvic structures after high-dose...
Radiology | Hematology, Oncology and Palliative Medicine | TOXICITY | ONCOLOGY | 3-DIMENSIONAL CONFORMAL RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PREDICTORS | Organs at Risk - radiation effects | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Humans | Radiotherapy, Intensity-Modulated - methods | Urogenital System - radiation effects | Male | Rectum - radiation effects | Radiation Dosage | Radiation Injuries - complications | Urinary Bladder - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Analysis of Variance | Surveys and Questionnaires | Aged | Urethra - radiation effects | Care and treatment | Radiotherapy | Nuclear radiation | Health aspects | Prostate cancer | Cancer | Index Medicus | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | BLADDER | RADIOTHERAPY | PLANNING | toxicity | radiotherapy | dose volume histogram | urogenital abnormalities | prostatic neoplasms
Radiology | Hematology, Oncology and Palliative Medicine | TOXICITY | ONCOLOGY | 3-DIMENSIONAL CONFORMAL RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PREDICTORS | Organs at Risk - radiation effects | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Humans | Radiotherapy, Intensity-Modulated - methods | Urogenital System - radiation effects | Male | Rectum - radiation effects | Radiation Dosage | Radiation Injuries - complications | Urinary Bladder - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Analysis of Variance | Surveys and Questionnaires | Aged | Urethra - radiation effects | Care and treatment | Radiotherapy | Nuclear radiation | Health aspects | Prostate cancer | Cancer | Index Medicus | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | BLADDER | RADIOTHERAPY | PLANNING | toxicity | radiotherapy | dose volume histogram | urogenital abnormalities | prostatic neoplasms
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 5, pp. 1254 - 1261
Purpose To analyze the effect of primary Gleason (pG) grade among a large cohort of Gleason 7 prostate cancer patients treated with external beam radiation...
Radiology | Hematology, Oncology and Palliative Medicine | SURVIVAL | IMPACT | SCORE | PATTERN | ONCOLOGY | MEN | GRADE | RADICAL PROSTATECTOMY | BRACHYTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Male | Neoplasm Recurrence, Local - mortality | Prostate - pathology | Neoplasm Grading | Neoplasm Invasiveness - pathology | Aged, 80 and over | Prostatic Neoplasms - blood | Adult | Retrospective Studies | Adenocarcinoma - radiotherapy | Prostatic Neoplasms - pathology | Adenocarcinoma - blood | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Disease-Free Survival | Radiotherapy, Conformal | Aged | Biopsy, Needle | Adenocarcinoma - mortality | Radiotherapy, Intensity-Modulated | Radiotherapy | Nuclear radiation | Health aspects | Analysis | MORTALITY | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | BIOPSY | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE
Radiology | Hematology, Oncology and Palliative Medicine | SURVIVAL | IMPACT | SCORE | PATTERN | ONCOLOGY | MEN | GRADE | RADICAL PROSTATECTOMY | BRACHYTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Male | Neoplasm Recurrence, Local - mortality | Prostate - pathology | Neoplasm Grading | Neoplasm Invasiveness - pathology | Aged, 80 and over | Prostatic Neoplasms - blood | Adult | Retrospective Studies | Adenocarcinoma - radiotherapy | Prostatic Neoplasms - pathology | Adenocarcinoma - blood | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Disease-Free Survival | Radiotherapy, Conformal | Aged | Biopsy, Needle | Adenocarcinoma - mortality | Radiotherapy, Intensity-Modulated | Radiotherapy | Nuclear radiation | Health aspects | Analysis | MORTALITY | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | BIOPSY | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 3, pp. 529 - 533
Purpose To determine whether the response to neoadjuvant androgen deprivation therapy (ADT) defined by a decline in prostate-specific antigen (PSA) to nadir...
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | DEFINITIVE RADIOTHERAPY | CONFORMAL RADIOTHERAPY | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ADJUVANT | Prostatic Neoplasms - pathology | Anilides - therapeutic use | Humans | Middle Aged | Radiation Tolerance | Proportional Hazards Models | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Disease-Free Survival | Neoadjuvant Therapy - mortality | Neoadjuvant Therapy - methods | Tosyl Compounds - therapeutic use | Androgen Antagonists - therapeutic use | Prostatic Neoplasms - blood | Radiotherapy, Conformal | Aged | Gonadotropin-Releasing Hormone - therapeutic use | Retrospective Studies | Nitriles - therapeutic use | PROSTATE | PATIENTS | EXTERNAL BEAM RADIATION THERAPY | RISK ASSESSMENT | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIATION DOSES | ANDROGENS
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | DEFINITIVE RADIOTHERAPY | CONFORMAL RADIOTHERAPY | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ADJUVANT | Prostatic Neoplasms - pathology | Anilides - therapeutic use | Humans | Middle Aged | Radiation Tolerance | Proportional Hazards Models | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Disease-Free Survival | Neoadjuvant Therapy - mortality | Neoadjuvant Therapy - methods | Tosyl Compounds - therapeutic use | Androgen Antagonists - therapeutic use | Prostatic Neoplasms - blood | Radiotherapy, Conformal | Aged | Gonadotropin-Releasing Hormone - therapeutic use | Retrospective Studies | Nitriles - therapeutic use | PROSTATE | PATIENTS | EXTERNAL BEAM RADIATION THERAPY | RISK ASSESSMENT | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIATION DOSES | ANDROGENS
Journal Article
Brachytherapy, ISSN 1538-4721, 2017, Volume 16, Issue 3, pp. S30 - S30
Journal Article
BJU International, ISSN 1464-4096, 09/2014, Volume 114, Issue 3, pp. 360 - 367
Objective To compare tumour control and toxicity outcomes with the use of high‐dose intensity‐modulated radiation therapy (IMRT) alone or brachytherapy...
intensity‐modulated radiotherapy | brachytherapy | distant metastases | PSA | intensity-modulated radiotherapy | MORTALITY | BOOST | RANDOMIZED-TRIAL | TOXICITY | COMBINATION | THERAPY | TERM ANDROGEN DEPRIVATION | UROLOGY & NEPHROLOGY | EXTERNAL-BEAM RADIATION | RADIOTHERAPY | STANDARD | Prostate-Specific Antigen | Radiotherapy Dosage | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Male | Treatment Outcome | Prostatic Neoplasms - mortality | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Aged | Brachytherapy | Radiotherapy, Intensity-Modulated | Radioisotope brachytherapy | Comparative analysis | Prostate cancer | Health aspects | Risk factors | Confidence intervals | Radiation therapy | Multivariate analysis | Cancer therapies | Index Medicus
intensity‐modulated radiotherapy | brachytherapy | distant metastases | PSA | intensity-modulated radiotherapy | MORTALITY | BOOST | RANDOMIZED-TRIAL | TOXICITY | COMBINATION | THERAPY | TERM ANDROGEN DEPRIVATION | UROLOGY & NEPHROLOGY | EXTERNAL-BEAM RADIATION | RADIOTHERAPY | STANDARD | Prostate-Specific Antigen | Radiotherapy Dosage | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Male | Treatment Outcome | Prostatic Neoplasms - mortality | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Aged | Brachytherapy | Radiotherapy, Intensity-Modulated | Radioisotope brachytherapy | Comparative analysis | Prostate cancer | Health aspects | Risk factors | Confidence intervals | Radiation therapy | Multivariate analysis | Cancer therapies | Index Medicus
Journal Article
Practical Radiation Oncology, ISSN 1879-8500, 09/2016, Volume 6, Issue 5, pp. e217 - e218
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.